|
 |
| 首頁
>> 新聞中心 |
|
 |
| 南非將開始 HIV 疫苗試驗 |
| 發(fā)布時間：
2016/11/29 |
一種新的預(yù)防HIV的疫苗將在南非投入臨床試驗，這種疫苗有可能安全地預(yù)防造成艾滋病的HIV病毒的感染。
根據(jù)美國國立衛(wèi)生研究院的聲明，HVTN 702 是迄今在南非進(jìn)行的最大規(guī)模、最先進(jìn)的HIV疫苗臨床試驗。南非有大約7百萬人攜帶HIV病毒。
美國國立衛(wèi)生研究院下屬的國家過敏和傳染病研究院院長安東尼?福奇表示，這項新研究是根據(jù)美國軍方艾滋病毒研究項目和泰國衛(wèi)生部先前在泰國進(jìn)行的一項研究而制定的。
這次試驗準(zhǔn)備從南非的15個地點招收5400名18到35歲有性行為的男性和女性。在南非，每天感染HIV病毒的新患者超過1000人。
這次臨床試驗結(jié)果預(yù)計將于2020年公布。加利福尼亞三清真寺收到威脅信
HIV Vaccine Trial To Begin In South Africa
A new clinical trial is taking place in South Africa on an experimental vaccine that could safely prevent infection with HIV, the virus that causes AIDS.
According to a statement from the National Institutes of Health (NIH), the HVTN 702 is the largest and most advanced HIV vaccine clinical trial to take place in South Africa, where some 7 million people are living with the virus.
The director of the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the NIH, Anthony S. Fauci said the new study is based on the one conducted in Thailand led by the U.S. Military HIV Research Program and the Thai Ministry of Health.
The study is expected to enroll 5,400 sexually active men and women between 18 and 35 at 15 sites across South Africa where more than 1,000 people a day are infected with HIV.
Results of the clinical trial are expected in 2020.
|
|
|
|
|
| |
|
網(wǎng)站管理 蘇ICP備16043401號